These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29312296)

  • 1. Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.
    Li P; Feng J; Liu Y; Liu Q; Fan L; Liu Q; She X; Liu C; Liu T; Zhao C; Wang W; Li G; Wu M
    Front Immunol; 2017; 8():1748. PubMed ID: 29312296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation.
    Feng J; Ren X; Fu H; Li D; Chen X; Zu X; Liu Q; Wu M
    Mol Ther Nucleic Acids; 2021 Dec; 26():473-487. PubMed ID: 34631278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells.
    Wang Z; Guo Q; Wang R; Xu G; Li P; Sun Y; She X; Liu Q; Chen Q; Yu Z; Liu C; Xiong J; Li G; Wu M
    J Hematol Oncol; 2016 Nov; 9(1):130. PubMed ID: 27884160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth.
    Tang H; Liu X; Wang Z; She X; Zeng X; Deng M; Liao Q; Guo X; Wang R; Li X; Zeng F; Wu M; Li G
    Brain Res; 2011 May; 1390():21-32. PubMed ID: 21435336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF-β pathway in human non-small cell lung cancer.
    Liu W; Wei X; Li L; Wu X; Yan J; Yang H; Song F
    Biochem Biophys Res Commun; 2017 Jun; 488(1):196-203. PubMed ID: 28487109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Li Z; Liu X; Guo R; Wang P
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):1-9. PubMed ID: 27644153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T
    Mitsdoerffer M; Aly L; Barz M; Engleitner T; Sie C; Delbridge C; Lepennetier G; Öllinger R; Pfaller M; Wiestler B; Rad R; Meyer B; Knier B; Schmidt-Graf F; Gempt J; Korn T
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206208119. PubMed ID: 35969754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
    Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF
    Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression absence of LRRC4 gene in glioblastoma cell lines].
    Wu MH; Li XL; Huang C; Tang YL; Zhang ZP; Li GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):231-4. PubMed ID: 17478928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells.
    Mrizak D; Martin N; Barjon C; Jimenez-Pailhes AS; Mustapha R; Niki T; Guigay J; Pancré V; de Launoit Y; Busson P; Moralès O; Delhem N
    J Natl Cancer Inst; 2015 Jan; 107(1):363. PubMed ID: 25505237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating CD8
    Abdoli Shadbad M; Miraki Feriz A; Baradaran B; Safarpour H
    Heliyon; 2024 Mar; 10(5):e27329. PubMed ID: 38495199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma.
    Deng K; Wu M
    Chin Med J (Engl); 2023 Jan; 136(1):4-12. PubMed ID: 36780420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
    Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
    PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.